Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

We build breakthrough biotechs

Biotech

Creating and building breakthrough biotechs for over 30 years

People

Partnering with the world's best life science entrepreneurs

Impact

Translating groundbreaking science into life-changing medicines
Scroll to explore
3
Latest news
Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinic
Find out more
Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal
Find out more
Atlas Venture 2024 Newsletter
Find out more
Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinic
Find out more
Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal
Find out more

Thirty years at the leading-edge of medical innovation and we’re just getting started.

~ Measuring our impact

>25

Medicines made by Atlas portfolio companies

~ Measuring our impact

70

Startups launched from the Atlas incubator

~ Measuring our impact

41

IPOs

~ Measuring our impact

36

M&A Exits